Wuxi Biologics (Cayman) Inc. KKPS DR (WUXI06) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,25%	1 104,10	+2,73	+0,25%	—	1 101,37	1 103,63	1 105,31	1 091,41	—	—
SIXC Communications SIXC Communications	SIXC −1,50%	604,16	−9,19	−1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE −0,09%	1 197,81	−1,02	−0,09%	—	1 198,83	1 199,68	1 199,75	1 182,41	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1 740,41	−15,54	−0,88%	—	1 755,95	1 754,06	1 756,03	1 734,69	—	—
SIXM Financials SIXM Financials	SIXM −0,64%	634,44	−4,07	−0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR −0,31%	840,90	−2,62	−0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,38%	215,13	−0,82	−0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3 228,71	+89,80	+2,86%	—	3 138,91	3 189,30	3 230,85	3 174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV −1,37%	1 457,12	−20,31	−1,37%	—	1 477,43	1 474,12	1 474,12	1 451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2 399,84	+19,65	+0,83%	—	2 380,19	2 389,34	2 403,04	2 380,47	—	—

WUXI06:BKK

Wuxi Biologics (Cayman) Inc. KKPS DR

3,48 THB

−0,57%

(−0,020) 1 D

27. apr., 16:40:00 GMT+7 · THB

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for WUXI06 …

Åpne

3,40 THB

Høy

3,48 THB

Lav

3,40 THB

Markedsverdi

137,71 mrd.

Snittvolum

35,30k

Volum

152,95k

52 u høy

4,28 THB

52 u lav

3,16 THB

Utestående aksjer

2,50 mrd.

Antall ansatte

13k

Relaterte aksjer

AIA06

Aia Group Limited KKPS DR

3,44 THB

+1,78%

ICBC06

Industrial and Commercial Bank of China

Nyhetssaker

Fra kilder på nettet

TipRanks

for 6 minutter siden

Greenlane Regains Nasdaq Compliance and Secures Warrant Lockup

GlobeNewswire

for 10 minutter siden

Vivakor Announces Uplisting to Nasdaq Capital Market

Yahoo Finance

for 12 minutter siden

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

MarketBeat

for 16 minutter siden

Baker Hughes (NASDAQ:BKR) Price Target Raised to $74.00

Profil

WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia

Om Wuxi Biologics (Cayman) Inc. KKPS DR

Administrerende direktørZhisheng Chen

Ansatte13,3k

Grunnlagt2010

Hovedkontor-

Sektor-

Nettstedwuxibiologics.com

Alle verdier i CNY	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	4,98 mrd.	4,98 mrd.	5,92 mrd.	5,92 mrd.
Varekostnad	2,85 mrd.	2,85 mrd.	3,04 mrd.	3,04 mrd.
Direkte driftskostnader	2,85 mrd.	2,85 mrd.	3,04 mrd.	3,04 mrd.
Utgifter til forskning og utvikling	171,76 mill.	171,76 mill.	254,93 mill.	254,93 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	525,62 mill.	525,62 mill.	631,03 mill.	631,03 mill.
Driftskostnader	764,30 mill.	764,30 mill.	921,71 mill.	921,71 mill.
Totale driftskostnader	3,61 mrd.	3,61 mrd.	3,96 mrd.	3,96 mrd.
Driftsinntekter	1,36 mrd.	1,36 mrd.	1,96 mrd.	1,96 mrd.
Andre ikke-operasjonelle inntekter	54,16 mill.	54,16 mill.	−283,76 mill.	−283,76 mill.
EBT inkludert uvanlige elementer	1,66 mrd.	1,66 mrd.	1,96 mrd.	1,96 mrd.
EBT uten uvanlige elementer	1,48 mrd.	1,48 mrd.	1,62 mrd.	1,62 mrd.
Kostnad for inntektsskatt	285,74 mill.	285,74 mill.	476,10 mill.	476,10 mill.
Faktisk avgiftssats	17,17 %	17,17 %	24,24 %	24,24 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	1,17 mrd.	1,17 mrd.	1,28 mrd.	1,28 mrd.
Netto fortjenestemargin	23,50 %	23,50 %	21,70 %	21,70 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	102,03 mill.	102,03 mill.	115,29 mill.	115,29 mill.
Rentekostnader	−41,77 mill.	−41,77 mill.	−29,76 mill.	−29,76 mill.
Netto rentekostnader	60,26 mill.	60,26 mill.	85,53 mill.	85,53 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	1,72 mrd.	1,72 mrd.	2,32 mrd.	2,28 mrd.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning